|
|
||||||||
by Cdk7-mediated phosphorylation
1 The Institute of Molecular and Cellular Biosciences, University of Tokyo, Bunkyo-ku, Tokyo, Japan
2 SORST, Japan Science and Technology, Kawaguchi, Saitama, Japan
Phosphorylation of the Ser118 residue in the N-terminal A/B domain of the human oestrogen receptor
(hER
) by mitogen-activated protein kinase (MAPK), stimulated via growth factor signalling pathways, is known to potentiate ER
ligand-induced transactivation function. Besides MAPK, cyclin dependent kinase 7 (Cdk7) in the TFIIH complex has also been found to potentiate hER
transactivation in vitro through Ser118 phosphorylation. To investigate an impact of Cdk7 on hER
transactivation in vivo, we assessed activity of hER
in a wild-type and cdk7 inactive mutant Drosophila that ectopically expressed hER
in the eye disc. Ectopic expression of the wild-type or mutant receptors, together with a green fluorescent protein (GFP) reporter gene, allowed us to demonstrate that hER
expressed in the fly tissues was transcriptionally functional and adequately responded to hER
ligands in the patterns similar to those observed in mammalian cells. Replacement of Ser118 with alanine in hER
(S118A mutant) significantly reduced the ligand-induced hER
transactivation function. Importantly, while in cdk7 inactive mutant Drosophila the wild-type hER
exhibited reduced response to the ligand; levels of transactivation by the hER
S118A mutant were not affected in these inactive cdk7 mutant flies. Furthermore, phosphorylation of hER
at Ser118 has been observed in vitro by both human and Drosophila Cdk7. Our findings demonstrate that Cdk7 is involved in regulation of the ligand-induced transactivation function of hER
in vivo via Ser118 phosphorylation.
* Correspondence: Email: uskato{at}mail.ecc.u-tokyo.ac.jp
This article has been cited by other articles:
![]() |
A. P. Kouzmenko, K.-i. Takeyama, Y. Kawasaki, T. Akiyama, and S. Kato Ligand-dependent interaction between estrogen receptor alpha and adenomatous polyposis coli. Genes Cells, July 1, 2008; 13(7): 723 - 730. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Acconcia, B. Manavathi, J. Mascarenhas, A. H. Talukder, G. Mills, and R. Kumar An Inherent Role of Integrin-Linked Kinase-Estrogen Receptor {alpha} Interaction in Cell Migration. Cancer Res., November 15, 2006; 66(22): 11030 - 11038. [Abstract] [Full Text] [PDF] |
||||
![]() |
N Sarwar, J-S Kim, J Jiang, D Peston, H D Sinnett, P Madden, J M Gee, R I Nicholson, A E Lykkesfeldt, S Shousha, et al. Phosphorylation of ER{alpha} at serine 118 in primary breast cancer and in tamoxifen-resistant tumours is indicative of a complex role for ER{alpha} phosphorylation in breast cancer progression. Endocr. Relat. Cancer, September 1, 2006; 13(3): 851 - 861. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ogawa, H. Oishi, Y. Mezaki, M. Kouzu-Fujita, R. Matsuyama, M. Nakagomi, E. Mori, E. Murayama, H. Nagasawa, H. Kitagawa, et al. Repressive domain of unliganded human estrogen receptor {alpha} associates with Hsc70 Genes Cells, December 1, 2005; 10(12): 1095 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Furutani, K.-i. Takeyama, M. Tanabe, H. Koutoku, S. Ito, N. Taniguchi, E. Suzuki, M. Kudoh, M. Shibasaki, H. Shikama, et al. Human Expanded Polyglutamine Androgen Receptor Mutants in Neurodegeneration as a Novel Ligand Target J. Pharmacol. Exp. Ther., November 1, 2005; 315(2): 545 - 552. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | ADVANCED SEARCH | TABLE OF CONTENTS |